Also trades as: PREV.CN (CNQ) · $vol 0M
PRVCF OTC
PreveCeutical Medical Inc.
1W: -42.8%
1M: -41.1%
3M: -22.3%
YTD: -41.8%
1Y: -56.2%
3Y: -46.4%
5Y: -48.5%
$0.01
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$427K
-43.7% ▼
Capital Expenditures
$2K
+0.0% ▲
5Y CAGR: +6.2%
Free Cash Flow
-$428K
-44.3% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$58K
+1476.6% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$4M | -$2M | -$1M | -$1M | -$1M |
| Depreciation & Amort. | $75K | $5K | $10K | $10K | $10K |
| Stock-Based Comp. | $1M | $90K | $334K | $131K | $76K |
| Change in Working Capital | $698K | $593K | $495K | $527K | $343K |
| Other Non-Cash Items | $2M | $633K | $442K | $309K | $318K |
| Operating Cash Flow | $65K | -$426K | -$223K | -$297K | -$427K |
| — Investing Activities — | |||||
| Capital Expenditures | -$3K | -$55K | $0 | $0 | -$2K |
| Acquisitions (Net) | $0 | $0 | $850 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | $2K | $0 | $0 | $0 |
| Investing Cash Flow | -$3K | -$53K | $850 | $0 | -$2K |
| — Financing Activities — | |||||
| Net Debt Issuance | $128K | $137K | $218K | $94K | $248K |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $54K | $0 | -$6K | $199K | $145K |
| Financing Cash Flow | $184K | $137K | $212K | $294K | $488K |
| Net Change in Cash | $128K | -$140K | -$10K | -$4K | $58K |
| Cash End of Period | $156K | $16K | $6K | $1K | $59K |
| Free Cash Flow | $62K | -$482K | -$223K | -$297K | -$428K |